The DOI matches its Crossref record, with a small difference in title or year; 46 of the 46 references it cites were found in a registry or an index.
The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group.
Open accessAbstract
OBJECTIVE: The Diabetes Prevention Program (DPP) is a 27-center randomized clinical trial designed to evaluate the safety and efficacy of interventions that may delay or prevent development of diabetes in people at increased risk for type 2 diabetes. RESEARCH DESIGN AND METHODS: Eligibility requirements were age > or = 25 years, BMI > or = 24 kg/m2 (> or = 22 kg/m2 for Asian-Americans), and impaired glucose tolerance plus a fasting plasma glucose of 5.3-6.9 mmol/l (or < or = 6.9 mmol for American Indians). Randomization of participants into the DPP over 2.7 years ended in June 1999. Baseline data for the three treatment groups--intensive lifestyle modification, standard care plus metformin, and standard care plus placebo--are presented for the 3,234 participants who have been randomized. RESULTS: Of all participants, 55% were Caucasian, 20% were African-American, 16% were Hispanic, 5% were American Indian, and 4% were Asian-American. Their average age at entry was 51 +/- 10.7 years (mean +/- SD), and 67.7% were women. Moreover, 16% were < 40 years of age, and 20% were > or = 60 years of age. Of the women, 48% were postmenopausal. Men and women had similar frequencies of history of hypercholesterolemia (37 and 33%, respectively) or hypertension (29 and 26%, respectively). On the basis of fasting lipid determinations, 54% of men and 40% of women fit National Cholesterol Education Program criteria for abnormal lipid profiles. More men than women were current or former cigarette smokers or had a history of coronary heart disease. Furthermore, 66% of men and 71% of women had a first-degree relative with diabetes. Overall, BMI averaged 34.0 +/- 6.7 kg/m2 at baseline with 57% of the men and 73% of women having a BMI > or = 30 kg/m2. Average fasting plasma glucose (6.0 +/- 0.5 mmol/l) and HbA1c (5.9 +/- 0.5%) in men were comparable with values in women (5.9 +/- 0.4 mmol/l and 5.9 +/- 0.5%, respectively). CONCLUSIONS: The DPP has successfully randomized a large cohort of participants with a wide distribution of age, obesity, and ethnic and racial backgrounds who are at high risk for developing type 2 diabetes. The study will examine the effects of interventions on the development of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dysglycemia is strongly associated with the development of overweight status or obesity, as most DM2 patients are overweight or obese (44–46).”
From GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin (2020) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Part of this paper’s reference list could not be split into single entries.
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Kumar, M. V. J., & Chippada, A. R. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Warnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,171
Eriksson, K. F., & Lindg�rde, F. (1991) · Diabetologia · doi:10.1007/bf00400196 · Cited by 1,092
(1999) · Diabetes Care · doi:10.2337/diacare.22.4.623 · Cited by 725
Statistical Considerations in the Intent-to-Treat Principle
Lachin, J. M. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00046-5 · Cited by 652
Edelstein, S. L., Knowler, W. C., Bain, R. P., Andres, R., Barrett-Connor, E. L., Dowse, G. K., Haffher, S. M., Pettitt, D. J., Sorkin, J. D., Muller, D. C., et al. (1997) · Diabetes · doi:10.2337/diab.46.4.701 · Cited by 641
Research works printed but not linked: 1
- [32]32. Hainline A Jr, Karon J, Lippel K (Eds.): Manual of Laboratory Operations. 2nd ed. Lipid Research Clinics Program, Lipid and Lipoprotein Analysis, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health (updated 1983)
Cited by
Sorted by citations
Items 301–399 of 399
Blair, Y. A., Doherty, L., Temprosa, M. G., Pop‐Busui, R., Gadde, K. M., Singh, P., Owora, A. H., Wessells, H., & Sarma, A. V. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108669 · Cited by 5
Diabetes mellitus tipo 2: fatores preditivos na população nipo-brasileira
do Nascimento, R., Franco, L. J., Gimeno, S. G. A., Hirai, A. T., & Ferreira, S. R. G. (2003) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302003000500013 · Cited by 5
Zweig, S. B., Tolentino, M. C., Strizhevsky, M., & Poretsky, L. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_33 · Cited by 5
Tang, M., Zhou, Y., Song, A., Wang, J., Wan, Y., & Xu, R. (2021) · Research Square · doi:10.21203/rs.3.rs-203515/v2 · Cited by 5
Long-term impact of Diabetes Prevention Program interventions on walking endurance
Munshi, M. N., Venditti, E. M., Tjaden, A. H., Knowler, W. C., Boyko, E. J., Middelbeek, R. J. W., Luchsinger, J. A., Lee, C. G., Hazuda, H. P., Salive, M. E., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1470035 · Cited by 4
Effects of visceral fat accumulation in obesity and type 2 diabetes
Fatati, G., Mirri, E., & Coaccioli, S. (2009) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1007/s12349-009-0048-1 · Cited by 4
Impaired glucose tolerance and metformin: clinical and mechanistic aspects
Hermann, L. S., & Wiernsperger, N. F. (2002) · The British Journal of Diabetes · doi:10.1177/14746514020020030501 · Cited by 4
Reducing the Incidence of Type 2 Diabetes Mellitus
Pronk, N. P., Boucher, J. L., Jeffery, R. W., Sherwood, N. E., & Boyle, R. (2004) · Disease Management & Health Outcomes · doi:10.2165/00115677-200412040-00005 · Cited by 4
The Prevention or Delay of Type 2 Diabetes
(2002) · Clinical Diabetes · doi:10.2337/diaclin.20.3.109 · Cited by 4
Bieda, J. (2009) · Deep Blue (University of Michigan) · Cited by 4
Lin, P. D., Cárdenas, A., Temprosa, M. G., Botelho, J. C., Calafat, A. M., Gold, D. R., Oken, E., & Fleisch, A. F. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.046298 · Cited by 3
A Systematic Review of Behavioral Interventions on Children at Risk for Diabetes
Alvarado, A. V., Burns, K. F., Katz, S. E., & Robson, S. M. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.01.021 · Cited by 3
Gupta, P., Doherty, L., Temprosa, M. G., Pop‐Busui, R., Gadde, K. M., Singh, P., Owora, A. H., Wessells, H., & Sarma, A. V. (2024) · Neurourology and Urodynamics · doi:10.1002/nau.25436 · Cited by 3
“The Diabetes Prevention Program (DPP), 6,7 and its observational follow ‐ up, the Diabetes Prevention Program Observational Study (DPPOS), demonstrated that intensive lifestyle intervention (ILS) and metformin both delayed the onset and progression of T2D among men and women with overweight/obesity…”
BackgroundThe Pillars of Prevention: Discover, Advocate, and Educate
Montgomery, B. K. (2018) · Diabetes Spectrum · doi:10.2337/ds17-0078 · Cited by 3
LeBlanc, E. S., Smith, N. X., Hwang, D., Young, D. R., Oshiro, C. E. S., Mayhew, M., Massimino, S., Catlin, C., & Clarke, G. N. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107796 · Cited by 3
Diabète gestationnel : où en sommes-nous en 2007 ?
Vambergue, A., Deruelle, P., Samouëlian, V., & Fontaine, P. (2008) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(08)71671-7 · Cited by 3
Aerobic exercise training versus the aetiology of insulin resistance
Yeo, S. E., & Coker, R. H. (2008) · European Journal of Sport Science · doi:10.1080/17461390701832645 · Cited by 4
“In general, moderate-intensity exercise is recommended on the basis that vigorous activity may be accompanied by increased risk of injury and/or dropout (Diabetes Prevention Program Research Group, 2000).”
BackgroundFood glycaemic index, satiety and chronic diseases
Batista, S. M. M., Teixeira, E., de Francisco, A., & de Assis, M. A. A. (2008) · British Food Journal · doi:10.1108/00070700810906598 · Cited by 4
Takata, Y., Ou, O., Nishida, H., & Sakagami, K. (2002) · Journal of Occupational Health · doi:10.1539/joh.44.28 · Cited by 4
Satterfield, D. W., & DeBruyn, L. M. (2005) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2005.06.005 · Cited by 3
Cardiovascular disease in diabetes: prevention and intervention
Goldberg, R. B., & Florez, H. J. (2001) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200104000-00008 · Cited by 3
Allison, K. C., McCuen‐Wurst, C., Raevsky, A., Holmes, N., Goldbach, M. M., Guerra, C. E., Rendle, K. A. S., Cadet, T. J., Krouse, R. S., & Tchou, J. C. (2024) · Obesity Science & Practice · doi:10.1002/osp4.70023 · Cited by 2
How effective are church‐based weight‐loss interventions among Black adults? A systematic review
Williams, L. B., Abufarsakh, B., Karle, E. R., Almogheer, Z. S., Coughlin, S. S., & Yeary, K. H. K. (2024) · Obesity · doi:10.1002/oby.24115 · Cited by 2
Liu, Y., Jesus, E. D., Goldbach, M. M., Krouse, R. S., Guerra, C. E., Rendle, K. A. S., Cadet, T. J., Allison, K. C., & Tchou, J. C. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08999-x · Cited by 2
“The GET-WEL Program was a 20-week program adapted from the Diabetes Prevention Program, [10] a well-validated program used previously for individuals with many presenting health issues, including cancer survivors [11, 12].”
Recent lifestyle trials in the prevention of type 2 diabetes
Tuomilehto, J. O., & Lindström, J. (2004) · International Congress Series · doi:10.1016/j.ics.2003.12.025 · Cited by 3
Is It Reasonable to Treat a Metabolic Syndrome as a Single Disease Entity?
Yoon, K. (2005) · Journal of the Korean Medical Association · doi:10.5124/jkma.2005.48.12.1179 · Cited by 2
A Trial to Test a Novel Approach to Diabetes Prevention
Taylor, H. A., Morales, C., & Wilfond, B. S. (2017) · The American Journal of Bioethics · doi:10.1080/15265161.2017.1366200 · Cited by 2
Prevention of Type 2 Diabetes Mellitus
Horton, E. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_50-1 · Cited by 2
Yeung, K.-F., Lee, Y. Q., Chong, M. F., Gandhi, M., Lam, A. Y. R., Julianty, S., Tan, G. C. S., Ho, E. T. L., Goh, S., Tan, G. S. W., et al. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-002966 · Cited by 3
Shapiro, A. L. B., Tjaden, A. H., Edelstein, S. L., Kahn, S. E., Srikanthan, P., Knowler, W. C., Venditti, E. M., Golden, S. H., Carmichael, O. T., & Luchsinger, J. A. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108764 · Cited by 3
Weight Management in Diabetes Prevention
Pi-Sunyer, X. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-400-1_12 · Cited by 2
Striving for a more active communityLessons from the diabetes prevention program and beyond
Kriska, A. M. (2002) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(02)00430-0 · Cited by 2
Blicklé, J. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70070-8 · Cited by 2
Sleep Debt and Postprandial Metabolic Function in Subclinical Cardiometabolic Pathophysiology
Hurwitz, B. E. (2012) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000e107 · Cited by 1
Protection of Random Assignment
Powell, L. H., Kaufmann, P. G., & Freedland, K. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-39330-4_8 · Cited by 1
Zhang, C., Salamon, J., & Zhang, R. (2022) · Nutrients · doi:10.3390/nu14235159 · Cited by 1
Fayaz, S. H., Hamajima, N., Frozanfar, M. K., Hamrah, M. H., Inthaphatha, S., Nishino, K., & Yamamoto, E. (2024) · PubMed Central · doi:10.18999/nagjms.86.4.564 · Cited by 1
“30,35 In this study, 40 years old or older, family history of HT, and intake of palaw 3 times per week or more were associated with HT. Older age, especially 65 years or older, and family history of HT were reported to be risk factors for HT in previous studies conducted in Afghanistan 13 and other…”
Yu, X., Zhao, Y., Wang, Y., Lu, W., Lu, W., Wu, W., & Wang, H. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107473 · Cited by 1
Benton, M., Goldsmith, K., Ching, S. M., Forbes, A., Nadal, I. P., Murphy, H. R., Sobri, N. H. M., Yusof, B. N. M., Basri, N. I., Ismail, I. Z., et al. (2026) · Diabetic Medicine · doi:10.1111/dme.70257 · Cited by 2
Wang, S., Huang, Q., Luo, Y., Luo, Y., Wu, H., Lian, Z., Ji, L., & Zou, X. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1746570 · Cited by 1
Obesity and the Metabolic Syndrome
Codario, R. A. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-441-8_5 · Cited by 1
Interventional Trials to Prevent Diabetes: Diabetes Prevention Program
Aroda, V. R., & Ratner, R. E. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3314-9_9 · Cited by 1
Jiang, L., Manson, S. M., Beals, J., Henderson, W. G., Huang, H., Acton, K. J., Roubideaux, Y. D., & and the Special Diabetes Program for Indians Diabetes Prevention Demonstration Project (2014) · Diabetes Care · doi:10.2337/dc13-1996 · Cited by 1
Stappen ter preventie van type 2 diabetes: fysieke inspanning, meer lopen of minder zitten?
Tudor‐Locke, C., & Schuna, J. M. (2013) · Nederlands Tijdschrift voor Diabetologie · doi:10.1007/s12467-013-0011-0 · Cited by 1
The ‘collateral benefits‘ of noninsulin therapies for Type 2 diabetes
Roe, E. D., PON, N. C., Hollander, P. A., & Raskin, P. (2013) · Diabetes Management · doi:10.2217/dmt.13.5 · Cited by 1
Iranparvar, M., معینی, د. ع. س. ح., Azizi, F., & Ebadi, A. G. (2007) · Intern J Endocrinol Metab · Cited by 1
Prevention of Type 2 Diabetes Mellitus
Horton, E. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_50 · Cited by 1
Statistical Methods to Evaluate Surrogate Markers
Parast, L. M., Tian, L., Cai, T., & Palaniappan, L. P. (2023) · Medical Care · doi:10.1097/mlr.0000000000001956 · Cited by 1
Basketbolda Çeviklik: Performans ve Başarı Arasındaki Köprü
Salman, K. (2024) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub635.c2744 · Cited by 1
Tjaden, A. H., Goldbaum, A. A., Edelstein, S. L., Heckman‐Stoddard, B. M., Reedy, J., Herman, W. H., Hoskin, M. A., Knowler, W. C., Schlögl, M., Temple, K. A., et al. (2025) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2025.07.011 · Cited by 1
Mather, K. J., Pan, Q., Knowler, W. C., Funahashi, T., Bray, G. A., Arakaki, R. F., Falkner, B. E., Sharma, K., & Goldstein, B. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136853 · Cited by 1
The Role of Diabetes Care and Its Contributions to the Field of Diabetes: A Profile in Progress
Reynolds, L., & GENUTH, S. M. (2018) · Diabetes Care · doi:10.2337/dci17-0021 · Cited by 1
Making lifestyle work : long-term effects in the prevention of type 2 diabetes
Roumen, C. (2009) · Research Publications (Maastricht University) · doi:10.26481/dis.20091106cr · Cited by 1
Pector, E. A., Schutta, M. H., & Seshadri, P. (2005) · Cited by 1
Preventing type 2 diabetes: what have we learned?
Nathan, D. M. (2003) · The British Journal of Diabetes · doi:10.1177/1474651403003001s0301 · Cited by 1
Evaluation of a Community-wide Diabetes Prevention Program
Cardona, M. (2011) · The Sydney eScholarship Repository (The University of Sydney) · Cited by 1
Longoria, K. D., STROEBEL, B. M., Gadgil, M. A., Perez, N. B., Lewis, K., Weiss, S., & Flowers, E. (2026) · medRxiv · doi:10.64898/2026.04.27.26351846 · Cited by 1
“This study was a secondary analysis of baseline data from a subset of participants in the Diabetes Prevention Program (DPP) trial (23–25).”
Modi, P. J. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-308-4_26
Romero, H., & Cunha, F. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Non-traditional predictors to evaluate dropout rates
Roary-Cook, M. C. (2008) · UA Campus Repository (The University of Arizona)
An Eating Frequency Prescription for a Behavioral Weight Loss Intervention
Bachman, J. L. (2011)
Vascular Abnormalities in the Prediabetic State
Caballero, A. E., Lim, S. C., Horton, E. S., & Veves, A. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-091-9_4
Prevention of Type 2 and Gestational Diabetes
Hamman, R. F., & Dabelea, D. (2010) · Wiley eBooks · doi:10.1002/9780470682807.ch5
Global Migration and Prevention of Diabetes
Bhowmik, B., Hjellset, V. T., & Hussain, A. (2013) · doi:10.1002/9781118661321.ch7
Bardsley, J. K., & Passaro, M. (2002) · Clinical Diabetes · doi:10.2337/diaclin.20.1.5
Hartford, L. A. (2008) · Montana State University ScholarWorks (Montana State University)
Management Strategies for Diabetes
Ahluwalia, R. (2012) · doi:10.1007/978-1-908517-81-4_2
Prevention of Type 2 Diabetes Mellitus
Horton, E. S. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_50
Polycystic Ovary Syndrome, Insulin Resistance and Cardiovascular Disease
Corcoran, M. H., & Ehrmann, D. A. (2002) · CRC Press eBooks · doi:10.1201/b14062-10
Type 2 diabetes mellitus (T2DM) onset and "remission".
Tangelloju, S. (2016) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2515
Behavior and Health Disparities
Kwabi‐Addo, B. (2017) · Springer eBooks · doi:10.1007/978-3-319-55865-3_6
Prevention of diabetes through lifestyle intervention
Drummen, M. (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20190124md
Prévention du diabète de type 2 par la metformine : le pour, le contre. La controverse se poursuit
Halimi, S. (2020) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2020.10.015
Bewegungsarmes Verhalten als Risikofaktor für Typ-2-Diabetes
Pavlicek, V. (2015) · Der Diabetologe · doi:10.1007/s11428-015-1389-7
(2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(200103/04)17:2
Rinninger, F., & Standl, E. (2003) · Springer eBooks · doi:10.1007/978-3-662-10475-0_50
Sánchez, L. F. P., & de la Morena, L. H. (2001) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(01)75484-9
Tang, M., Zhou, Y., Wang, J., Wan, Y., & Xu, R. (2021) · Research Square · doi:10.21203/rs.3.rs-203515/v1
Rinninger, F., & Standl, E. (2006) · Springer eBooks · doi:10.1007/3-540-26504-x_50
Srikanthan, P., Pessin, J. E., & Bar, R. S. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-378-1_5
Detection and Diagnosis of Syndromes of Insulin Resistance and of Diabetes Mellitus
Horton, E. S. (2002) · CRC Press eBooks · doi:10.1201/9780203910382.ch8
Iwańska, A., Wójcik, M., Szczudlik, E., Stępniewska, A., & Starzyk, J. (2024) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2024.2023-8-9 · Cited by 1
Spor Bilimleri Alanında Akademik Araştırma ve Değerlendirmeler VIII
Mutlu, T. O., Kaya, E., Bingöl, E., Menteş, G., Aktaş, F., Aktaş, Y., Çoban, C., Heb, S., Şentürk, H. E., Salman, K., et al. (2024) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub635
Genç Boksörlerde Bağıl Yaş, Zihinsel Dayanıklılık ve Algılanan Performans
Ceylan, E., & Mülazımoğlu, O. (2024) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub635.c2746
E-Sporcularda Performans Kaygısı ve Stres Yönetimi
Menteş, G. (2024) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub635.c2740
Aktaş, Y., & Çoban, C. (2024) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub635.c2742
Beden Eğitimi ve Spor Öğretiminde Mesleki Kişilik Tiplerinin Önemi
Heb, S., & Şentürk, H. E. (2024) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub635.c2743
Jesus, E. D., Woo, S., Krouse, R. S., Guerra, C. E., Rendle, K. A. S., Cadet, T. J., Allison, K. C., & Tchou, J. C. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10548-7
AlSamghan, A. S., Mahmood, S. E., Ahmad, A., & Alsaleem, M. A. (2025) · Medicine · doi:10.1097/md.0000000000045804
“[17] The elevated HbA1c and serum fasting glucose levels in our study indicate a high prevalence of poorly controlled diabetes, which is a common comorbidity of obesity.”
Guo, J., Li, Z., Patel, S. A., CHANG, H. H., Ali, M. S., & Varghese, J. S. (2026) · Diabetes Care · doi:10.2337/dc25-2069
MicroRNAs modify relationships between hemoglobin A1c and race and ethnicity
STROEBEL, B. M., Aouizerat, B. E., Longoria, K. D., Gadgil, M. D., & Flowers, E. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113165
Varghese, J. S., Guo, J., Hua, D., Hung, T., Li, Z. T., Tang, S., Patel, S. A., & Ho, J. C. (2026) · medRxiv · doi:10.64898/2026.06.01.26354645
Longoria, K. D., STROEBEL, B. M., Gadgil, M. D., Weiss, S. J., Lewis, K., Perez, N. B., & Flowers, E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.10.731370
“Details of the parent DPP trial have been described in detail previously [23–25].”
Longoria, K. D., STROEBEL, B. M., Gadgil, M., Perez, N. B., Lewis, K., Weiss, S. J., & Flowers, E. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1816057
“This study was a secondary analysis of baseline data from a subset of participants in the Diabetes Prevention Program (DPP) trial (23 – 25).”
STROEBEL, B. M., Jimenez, A., Lindquist, K. J., Torgerson, D., Longoria, K. D., Ignacio‐Espinoza, J. C., & Flowers, E. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2026.1934355
Prevention of diabetes and early detection of prediabetes
Lilly, K. M. (2014) · Memorial University Research Repository (Memorial University)
Metadata
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2000-11-01
- Volume
- 23
- Issue
- 11
- Pages
- 1619-1629
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC1360735
- OpenAlex
- W1935237410
- Cited by
- 399
- References
- 44
- Citations by year
- 2026: 11 · 2025: 9 · 2024: 19 · 2023: 8 · 2022: 6 · 2021: 10 · 2020: 12 · 2019: 11 · 2018: 10 · 2017: 18 · 2016: 16 · 2015: 16 · 2014: 17 · 2013: 17 · 2012: 22
- FWCI
- 12.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Diabetes Association
- Bristol-Myers Squibb
- National Institutes of Health
- Centers for Disease Control and Prevention
- National Institute on Aging
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK048489)
- National Institute of Child Health and Human Development
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes prevention, impaired glucose tolerance, prediabetes, metformin, lifestyle modification, baseline characteristics, sex differences, racial and ethnic differences, body mass index, fasting blood glucose, HbA1c, hypercholesterolemia, hypertension, smoking, coronary artery disease, Diabetes Prevention Program
- MeSH terms
- Adult, Asian, Black or African American, Blood Glucose, Blood Pressure, Cholesterol, Coronary Disease, Diabetes Mellitus, Type 2, Female, Hispanic or Latino, Humans, Hypercholesterolemia, Indians, North American, Lipids, Male, Middle Aged, Patient Education as Topic, Risk Factors, Sex Factors, Smoking, Socioeconomic Factors, United States, Cohort Studies, Body Mass Index, Glucose Intolerance, White People, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review